First, the effectiveness of NT-proBNP in guiding HF therapy occasionally leads to contradictory result, especially in elderly patients, despite their NT-proBNP being apparently improve (26), whereas serum CA125 production was not influenced by age, sex or renal function, which bypasses many of the limitations of NT-proBNP (41). This evidence concerns the gene MUC16 and hydrops fetalis.